Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02260921 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
A NA study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT02260921 is a NA study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 180 participants.
The verdict
NCT02260921, a NA study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
This purpose of this study is to evaluate the effectiveness and safety of the iovera° device for the temporary reduction of pain associated with knee osteoarthritis.
Interventions
- DEVICE Sham Comparator
- DEVICE iovera°
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2014-10-20 |
| Est. Completion | 2016-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02260921
The ClinicalTrials.gov registry entry for NCT02260921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Comparator is the first listed.
NCT02260921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02260921 about?
NCT02260921 is a clinical study titled "Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain". This purpose of this study is to evaluate the effectiveness and safety of the iovera° device for the temporary reduction of pain associated with knee osteoarthritis.
What is the current status of trial NCT02260921?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2014-10-20. Estimated completion is 2016-05-31.
What interventions are being tested in trial NCT02260921?
The interventions under investigation include: Sham Comparator (DEVICE), iovera° (DEVICE).
Who is sponsoring clinical trial NCT02260921?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.